Hint mode is switched on Switch off
For swift navigation between sections

Stablecoin Development
LEI 549300D5U7PQPNEX8Q38

PDF download

Choose all Reset all
Download Cancel
Organization name
Stablecoin Development Corp
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

NovaBay Pharmaceuticals Inc operates as a biopharmacetical company that is focused on commercialization and developing products that address the topical anti-infective markets.

Awards

News

15/07/2026 Stablecoin Development: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
12/06/2026 Stablecoin Development: Entry Into A Material Definitive Agreement, Material Modification To Rights Of Security Holders, Financial Statements And Exhibits
20/05/2026 Stablecoin Development: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
27/04/2026 Stablecoin Development: Nonreliance On Previously Issued Financial Statements Or A Related Audit Report Or Completed Interim Review
06/04/2026 NovaBay Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
II q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300D5U7PQPNEX8Q38
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001389545
  • EIN
    68-0454536
Registration is required to get access.